INTRODUCTION
Patients with ulcerative colitis or Crohn’s colitis have an increased risk of colorectal cancer (CRC). Most cases are believed to arise from dysplasia, and surveillance colonos- copy therefore is recommended to detect dysplasia. Detec- tion of dysplasia traditionally has relied on both examination of the mucosa with targeted biopsies of visible lesions and extensive random biopsies to identify invisible dysplasia ... Please click here to read the full text version of this consensus statement.
Gastrointestinal Endoscopy, 2015, 81 (3)
Copyright a 2015 by the American Society for Gastrointestinal Endoscopy and American Gastroenterological Association
http://dx.doi.org/10.1016/j.gie.2014.12.009
Patients with ulcerative colitis or Crohn’s colitis have an increased risk of colorectal cancer (CRC). Most cases are believed to arise from dysplasia, and surveillance colonos- copy therefore is recommended to detect dysplasia. Detec- tion of dysplasia traditionally has relied on both examination of the mucosa with targeted biopsies of visible lesions and extensive random biopsies to identify invisible dysplasia ... Please click here to read the full text version of this consensus statement.
Gastrointestinal Endoscopy, 2015, 81 (3)
Copyright a 2015 by the American Society for Gastrointestinal Endoscopy and American Gastroenterological Association
http://dx.doi.org/10.1016/j.gie.2014.12.009
RSS Feed